Abstract:Objective To diagnose and perform individualized evidence-based treatment for a patient with alveolar osteonecrosis who is suspected of bone metastases.Methods Based on the clinical questions we raised,the relative evidences were collected and critically assessed,patient's preferences were also taken into account in the decision-making treatment.Results There were 1 randomized controlled trial,5 clinical guidelines(based on case reports or expert opinion analysis),4 prospective controlled trials,10 cases reports,and 1 expert opinion were considered eligible.The evidences indicated that:⑴cases of bisphosphonate-related osteonecrosis of the jaw(BONJ) were first described in 2003 as a potentially serious complication related to the use of bisphosphonates(BP).As more cases were reported,the disease has received much international attention.⑵The pathogenesis and the best way of managing BONJ remains unknown.There is currently no consensus on the exact diagnostic criteria,the criteria given by the American Association of Oral and Maxillofacial Surgeons(AAOMS) is used most widely.⑶Non-surgical management is recommend at early stage;a surgical approach mainly including debridement is based on the exposed bone;radical management refers to resection of bone beyond the alveolus and is recommended where there is large segment of necrotic bone or pathological fracture.⑷Radiographic evaluation can be helpful for prevention and diagnosis of early BONJ.⑸Because of long half-life of BP,discontinuation of BP therapy can not relieve the symptoms but may be good for wound healing after alveolar surgery.Modification or cessation of BP therapy should be done in consultation with the physician and the patient.⑹There is some consensus for the need for careful dental preparation of patients prior to BP therapy.Patients should be instructed in the clinical signs and symptoms of BONJ and avoid alveolar surgery during BP therapy.The individualized treatment plans were developed based on the available evidence and the patient's preferences.Local debridement was done in right maxillary lesions to remove necrotic bone;an excision of torus of bilateral tuber maxillae was undertaken for prosthodontics after informing the risk of BONJ.After 14 months of follow-up,the patient is nearly recovery.Conclusion BONJ is a new disease without definite pathogenesis and unified criteria.The treatment efficacy in BONJ has been improved by determining an individualized treatment plan according to evidence-based approach.

Bisphosphonate-related osteonecrosis of jaw:case report and literature reviews

[Bisphosphonate-Related Osteonecrosis of the Jaw Caused by Implant: a Case Report].

Bisphosphonate-Associated Osteonecrosis Of The Jaw In Oncology Patient: Case Report.

[Clinical Analysis of 24 Cases of Bisphosphonate-Related Osteonecrosis of the Jaw].

[Clinical Analysis of Bisphosphonate-Related Osteonecrosis of the Jaw].

Mechanism and risk assessment of bisphosphonate-related osteonecrosis of the jaw

Advances in the Research of Bisphosphonate-Associated Osteonecrosis of the Jaws

[Bilateral maxillary bisphosphonate-related osteonecrosis of the jaw: a case report].

[Osteonecrosis of the jaws associated with bisphosphonates: five cases]

[Clinical Features of Osteonecrosis of Jaws after Bisphosphonates Therapy for Bone Metastasis of Breast Cancer].

Drug induced osteonecrosis of the jaw

Complete Jaw Resection For The Treatment Of Bisphosphonate-Related Osteonecrosis - Case Report.

Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

Clinical Study of Bisphosphonate⁃related Osteonecrosis of the Jaws

Evidence-based diagnosis and treatment of bisphosphonate related osteonecrosis: report of 3 cases

Bisphosphonate-related osteonecrosis of the jaw: report of 9 cases

Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature

Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review

An Evidence-based Diagnosis and Treatment for Bisphosphonate-related Osteonecrosis of the Jaw

Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias

Osteonecrosis of the jaw induced by arsenic trioxide therapy in acute promyelocytic leukemia patient: a case report and literature review